Pay in 4 interest-free payments of $5.78 Learn more
Ships within 48 hours · Estimated delivery Nov 10 - Nov 15
Changes in the microbiota composition are observed in pre-cirrhotic patients with CLD, including the reduction of the diversity and overgrowth of the potentially pathogenic Enterobacteriaceae and Enterococcaceae
This peptide has gained attention as a fat-burning peptide with potential benefits for weight management
Important Note on the Evidence Base Important note on the evidence base: Peer-reviewed BPC-157 research has been conducted predominantly in rodent models (Sprague-Dawley and Wistar rats), with a smaller body of in vitro work on isolated fibroblasts, endothelial cells, and tendon explants
In the same model it was found that treatment increased responses to polyinosinic:polycytidylic acid (poly I:C), an antiviral ligand, and type I interferons, further supporting the antiviral properties of vitamin C in airway cells and potentially providing a way to combat air pollution-induced dysregulation of antiviral immune responses
